Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation: Results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) Study

M. Cristina Polidori, Domenico Praticó, Tiziana Ingegni, Elena Mariani, Liana Spazzafumo, Paola Del Sindaco, Roberta Cecchetti, Yuemang Yao, Stefano Ricci, Antonio Cherubini, Wilhelm Stahl, Helmut Sies, Umberto Senin, Patrizia Mecocci

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

A condition of oxidative stress is known to occur in ischemic stroke, the current therapeutic intervention of which is largely limited to thrombolysis. To assess the effect of vitamin C - in conjunction to aspirin - in ischemic stroke-related lipid peroxidation, we measured plasma levels of ascorbate, of 8,12-isoprostanes F-VI (8,12-iPF-VI) and activities and levels of a broad spectrum of antioxidant enzymes and micronutrients in stroke patients randomized to receive, from stroke onset and up to three months, either vitamin C (200 mg/day) plus aspirin (300 mg/day) or only aspirin (300 mg/day). By the end of the first week, patients treated with vitamin C plus aspirin had higher vitamin C levels (p = 0.02) and lower 8,12-iPF-VI levels (p = 0.01) than patients treated with aspirin alone. The significance was maintained for the increase of vitamin C after three months of therapy (p <0.01). The clinical functional outcome for both groups of patients similarly ameliorated after three months of treatment. We conclude that vitamin C, at the dose of 200 mg/day and in conjunction with aspirin, significantly decreases ischemic stroke-related lipid peroxidation in humans. Further studies are warranted to clarify whether the use of vitamin C may add clinical long-term beneficial effects in patients with stroke.

Original languageEnglish
Pages (from-to)265-274
Number of pages10
JournalBioFactors
Volume24
Issue number1-4
Publication statusPublished - 2005

Fingerprint

Lipid Peroxidation
Aspirin
Ascorbic Acid
Stroke
Lipids
8-epi-prostaglandin F2alpha
F2-Isoprostanes
Oxidative stress
Micronutrients
aspirin drug combination ascorbic acid
Oxidative Stress
Therapeutics
Antioxidants
Plasmas
Enzymes

Keywords

  • Aspirin
  • Ischemic stroke
  • Isoprostanes
  • Oxidative stress
  • Vitamin C

ASJC Scopus subject areas

  • Biochemistry

Cite this

Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation : Results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) Study. / Polidori, M. Cristina; Praticó, Domenico; Ingegni, Tiziana; Mariani, Elena; Spazzafumo, Liana; Sindaco, Paola Del; Cecchetti, Roberta; Yao, Yuemang; Ricci, Stefano; Cherubini, Antonio; Stahl, Wilhelm; Sies, Helmut; Senin, Umberto; Mecocci, Patrizia.

In: BioFactors, Vol. 24, No. 1-4, 2005, p. 265-274.

Research output: Contribution to journalArticle

Polidori, MC, Praticó, D, Ingegni, T, Mariani, E, Spazzafumo, L, Sindaco, PD, Cecchetti, R, Yao, Y, Ricci, S, Cherubini, A, Stahl, W, Sies, H, Senin, U & Mecocci, P 2005, 'Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation: Results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) Study', BioFactors, vol. 24, no. 1-4, pp. 265-274.
Polidori, M. Cristina ; Praticó, Domenico ; Ingegni, Tiziana ; Mariani, Elena ; Spazzafumo, Liana ; Sindaco, Paola Del ; Cecchetti, Roberta ; Yao, Yuemang ; Ricci, Stefano ; Cherubini, Antonio ; Stahl, Wilhelm ; Sies, Helmut ; Senin, Umberto ; Mecocci, Patrizia. / Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation : Results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) Study. In: BioFactors. 2005 ; Vol. 24, No. 1-4. pp. 265-274.
@article{6909e5e64a2c42389ee826c88ae4eb58,
title = "Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation: Results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) Study",
abstract = "A condition of oxidative stress is known to occur in ischemic stroke, the current therapeutic intervention of which is largely limited to thrombolysis. To assess the effect of vitamin C - in conjunction to aspirin - in ischemic stroke-related lipid peroxidation, we measured plasma levels of ascorbate, of 8,12-isoprostanes F2α-VI (8,12-iPF2α-VI) and activities and levels of a broad spectrum of antioxidant enzymes and micronutrients in stroke patients randomized to receive, from stroke onset and up to three months, either vitamin C (200 mg/day) plus aspirin (300 mg/day) or only aspirin (300 mg/day). By the end of the first week, patients treated with vitamin C plus aspirin had higher vitamin C levels (p = 0.02) and lower 8,12-iPF2α-VI levels (p = 0.01) than patients treated with aspirin alone. The significance was maintained for the increase of vitamin C after three months of therapy (p <0.01). The clinical functional outcome for both groups of patients similarly ameliorated after three months of treatment. We conclude that vitamin C, at the dose of 200 mg/day and in conjunction with aspirin, significantly decreases ischemic stroke-related lipid peroxidation in humans. Further studies are warranted to clarify whether the use of vitamin C may add clinical long-term beneficial effects in patients with stroke.",
keywords = "Aspirin, Ischemic stroke, Isoprostanes, Oxidative stress, Vitamin C",
author = "Polidori, {M. Cristina} and Domenico Pratic{\'o} and Tiziana Ingegni and Elena Mariani and Liana Spazzafumo and Sindaco, {Paola Del} and Roberta Cecchetti and Yuemang Yao and Stefano Ricci and Antonio Cherubini and Wilhelm Stahl and Helmut Sies and Umberto Senin and Patrizia Mecocci",
year = "2005",
language = "English",
volume = "24",
pages = "265--274",
journal = "BioFactors",
issn = "0951-6433",
publisher = "Wiley-Blackwell",
number = "1-4",

}

TY - JOUR

T1 - Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation

T2 - Results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) Study

AU - Polidori, M. Cristina

AU - Praticó, Domenico

AU - Ingegni, Tiziana

AU - Mariani, Elena

AU - Spazzafumo, Liana

AU - Sindaco, Paola Del

AU - Cecchetti, Roberta

AU - Yao, Yuemang

AU - Ricci, Stefano

AU - Cherubini, Antonio

AU - Stahl, Wilhelm

AU - Sies, Helmut

AU - Senin, Umberto

AU - Mecocci, Patrizia

PY - 2005

Y1 - 2005

N2 - A condition of oxidative stress is known to occur in ischemic stroke, the current therapeutic intervention of which is largely limited to thrombolysis. To assess the effect of vitamin C - in conjunction to aspirin - in ischemic stroke-related lipid peroxidation, we measured plasma levels of ascorbate, of 8,12-isoprostanes F2α-VI (8,12-iPF2α-VI) and activities and levels of a broad spectrum of antioxidant enzymes and micronutrients in stroke patients randomized to receive, from stroke onset and up to three months, either vitamin C (200 mg/day) plus aspirin (300 mg/day) or only aspirin (300 mg/day). By the end of the first week, patients treated with vitamin C plus aspirin had higher vitamin C levels (p = 0.02) and lower 8,12-iPF2α-VI levels (p = 0.01) than patients treated with aspirin alone. The significance was maintained for the increase of vitamin C after three months of therapy (p <0.01). The clinical functional outcome for both groups of patients similarly ameliorated after three months of treatment. We conclude that vitamin C, at the dose of 200 mg/day and in conjunction with aspirin, significantly decreases ischemic stroke-related lipid peroxidation in humans. Further studies are warranted to clarify whether the use of vitamin C may add clinical long-term beneficial effects in patients with stroke.

AB - A condition of oxidative stress is known to occur in ischemic stroke, the current therapeutic intervention of which is largely limited to thrombolysis. To assess the effect of vitamin C - in conjunction to aspirin - in ischemic stroke-related lipid peroxidation, we measured plasma levels of ascorbate, of 8,12-isoprostanes F2α-VI (8,12-iPF2α-VI) and activities and levels of a broad spectrum of antioxidant enzymes and micronutrients in stroke patients randomized to receive, from stroke onset and up to three months, either vitamin C (200 mg/day) plus aspirin (300 mg/day) or only aspirin (300 mg/day). By the end of the first week, patients treated with vitamin C plus aspirin had higher vitamin C levels (p = 0.02) and lower 8,12-iPF2α-VI levels (p = 0.01) than patients treated with aspirin alone. The significance was maintained for the increase of vitamin C after three months of therapy (p <0.01). The clinical functional outcome for both groups of patients similarly ameliorated after three months of treatment. We conclude that vitamin C, at the dose of 200 mg/day and in conjunction with aspirin, significantly decreases ischemic stroke-related lipid peroxidation in humans. Further studies are warranted to clarify whether the use of vitamin C may add clinical long-term beneficial effects in patients with stroke.

KW - Aspirin

KW - Ischemic stroke

KW - Isoprostanes

KW - Oxidative stress

KW - Vitamin C

UR - http://www.scopus.com/inward/record.url?scp=28644437628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28644437628&partnerID=8YFLogxK

M3 - Article

C2 - 16403987

AN - SCOPUS:28644437628

VL - 24

SP - 265

EP - 274

JO - BioFactors

JF - BioFactors

SN - 0951-6433

IS - 1-4

ER -